Cidara Therapeutics, Inc.
CDTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $190 | $36 | $33 | $62 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $16 | $6 | $5 |
| Inventory | $0 | $6 | $0 | -$3 |
| Other Curr. Assets | $19 | $3 | $0 | $3 |
| Total Curr. Assets | $211 | $61 | $45 | $72 |
| Property Plant & Equip (Net) | $4 | $5 | $1 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $1 |
| Other NC Assets | $0 | $1 | $1 | $1 |
| Total NC Assets | $4 | $6 | $2 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $215 | $67 | $47 | $75 |
| Liabilities | – | – | – | – |
| Payables | $4 | $4 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $3 |
| Tax Payable | $26 | $18 | $12 | $0 |
| Deferred Revenue | $0 | $25 | $15 | $14 |
| Other Curr. Liab. | $44 | $32 | $5 | $10 |
| Total Curr. Liab. | $50 | $67 | $41 | $34 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $4 | $21 | $18 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $8 | $21 | $20 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $5 | $1 | $2 |
| Total Liabilities | $51 | $75 | $62 | $54 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$611 | -$441 | -$419 | -$377 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $163 | -$8 | -$14 | $22 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $215 | $67 | $47 | $75 |
| Net Debt | -$190 | -$36 | -$33 | -$60 |